Collegium Pharmaceutical
COLL
60 hedge funds and large institutions have $327M invested in Collegium Pharmaceutical in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 4 closing their positions.
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
62% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 13
44% more capital invested
Capital invested by funds: $227M → $327M (+$100M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
22% more funds holding
Funds holding: 49 → 60 (+11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.13M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.74M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.92M |
| 4 |
HM
HealthCor Management
New York
|
+$1.58M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$14.7M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$4.08M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.52M |
| 4 |
EMG
Ellington Management Group
Old Greenwich,
Connecticut
|
-$604K |
| 5 |
Renaissance Technologies
New York
|
-$419K |
COLL Hedge Fund Activity: Q4 2015 in Review
60 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2015, worth a combined $327M — up 44% from $227M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new COLL positions and 4 closed out — a net gain of 11 holders — while 21 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $5.13M. The largest seller was RA Capital Management, cutting an estimated $14.7M.
- 60 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2015, up from 49 in Q3 2015.
- Funds reported $327M of Collegium Pharmaceutical stock for Q4 2015, up 44% quarter-over-quarter.
- 15 funds opened new Collegium Pharmaceutical positions in Q4 2015 and 4 closed out, a net change of +11 holders.
- The largest Collegium Pharmaceutical buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $5.13M added.
- The largest Collegium Pharmaceutical seller in Q4 2015 was RA Capital Management, an estimated $14.7M sold.
Based on aggregated 13F filings for Q4 2015.